Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma

Neoantigens represent promising targets for personalized cancer vaccine strategies. However, the feasibility of this approach in lower mutational burden tumors like glioblastoma (GBM) remains unknown. We have previously reported the use of an immunogenomics pipeline to identify candidate neoantigens...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Johanns, Tanner M., Miller, Christopher A., Liu, Connor J., Perrin, Richard J., Bender, Diane, Kobayashi, Dale K., Campian, Jian L., Chicoine, Michael R., Dacey, Ralph G., Huang, Jiayi, Fritsch, Edward F., Gillanders, William E., Artyomov, Maxim N., Mardis, Elaine R., Schreiber, Robert D., Dunn, Gavin P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2019
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422384/
https://ncbi.nlm.nih.gov/pubmed/30906654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1561106
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak